comprehensive -WSS

comprehensive

author：explore 2025-10-02 21:36:14 - browse：5

Monica Bertagnolli -- Health Policy coverage from STAT — Monica Bertagnolli, the nominee to lead the National Institutes of Health Jeff Chiu/AP

Monica Bertagnolli, President Biden’s nominee to lead the National Institutes of Health, spent her confirmation hearing Wednesday stuck in the middle of Republicans’ and Democrats’ bickering over her agency’s role in high drug costs, ultimately refusing to commit to either party’s approach.

Bertagnolli similarly walked a line on government funding for gender-affirming care research and other hotly politicized health care issues, though she did stress that transgender youth are some of the country’s most vulnerable people.

The long-awaited hearing came months after Committee Chairman Bernie Sanders (I-Vt.) pledged to stall her confirmation process until Biden did more to address high drug prices, like an assurance that the NIH would insert reasonable pricing requirements into deals with commercial drugmakers.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

WSS

VC firm General Catalyst wants to buy a health system

Medicare Advantage proposed rates disappoint insurers

Key House Republican on health care plans exit from Congress

BioAge raises $170M for combination therapy with Zepbound

Bill would stop addiction treatment from triggering child abuse inquiry

A ‘polypill’ could sharply reduce cardiovascular disease in the U.S.

focus

comprehensive

leisure time

23andMe had bad news about my health. I wish a person had delivered it

Senators start work on Medicare physician payment reform

Apple is now the first public company to be valued at $3 trillion

Was Amgen transparent enough on FDA's concern on cancer drug?

Sports medicine is finally prioritizing gender equality

The future of health care in the House

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Stroke deaths set to near 10 million globally by 2050

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

KalVista pill reduced swelling 'attacks' caused by genetic disease

hotspot

VC firm General Catalyst wants to buy a health system

The future of health care in the House

Industry veterans launch new biotech VC with $310M

A ‘polypill’ could sharply reduce cardiovascular disease in the U.S.

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

To avoid data mishandling cases, universities eye AI and other tools

Wikipedia

Wikipedia

knowledge

explore